Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Published:2013-01-08 Issue:2 Volume:9 Page:106-118
ISSN:1759-4758
Container-title:Nature Reviews Neurology
language:en
Short-container-title:Nat Rev Neurol

Author:

Liu Chia-Chen,Kanekiyo Takahisa,Xu Huaxi,Bu Guojun

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Link

http://www.nature.com/articles/nrneurol.2012.263.pdf

Reference178 articles.

1. Alzheimer's Association. 2012 Alzheimer's disease facts and figures. Alzheimers Dement. 8, 131–168 (2012).

2. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002).

3. Blennow, K., de Leon, M. J. & Zetterberg, H. Alzheimer's disease. Lancet 368, 387–403 (2006).

4. Roberson, E. D. et al. Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316, 750–754 (2007).

5. Zheng, H. & Koo, E. Biology and pathophysiology of the amyloid precursor protein. Mol. Neurodegener. 6, 27 (2011).

Cited by 2523 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between brain structure and dual decline in gait and cognition;Neurobiology of Aging;2024-11

2. Pharmacological Approaches and Herbal Interventions for Alzheimer's Disease;The Natural Products Journal;2024-11

3. Lipid measures are associated with cognitive functioning in multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2024-11

4. Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier;Ageing Research Reviews;2024-11

5. Pharmacokinetic study and neuropharmacological effects of atractylenolide Ⅲ to improve cognitive impairment via PI3K/AKT/GSK3β pathway in intracerebroventricular-streptozotocin rats;Journal of Ethnopharmacology;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3